N-Acetyl Selank

Experimental Peptide

N-acetyl Selank is a terminally modified derivative sold as a research chemical. Some products also add C-terminal amidation, creating another distinct identity.

Pharmacokinetic model

A route-level PK model for n-acetyl selank is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category: Experimental Peptide
Suggested cadence: once daily

Research behind this entry

Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank in the therapy of generalized anxiety disorders and neurasthenia Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2008
Sixty-two patients received parent Selank or medazepam in a Russian comparative trial. The publication concerns unmodified Selank and provides no compound-specific evidence for N-acetyl Selank.

1 published study referenced in the app, each with a plain-language summary.